Upcoming Dialogues - Fall Programs

Nontuberculous Mycobacteria (NTM), Bronchiectasis and COVID-19: Research and Treatment Update

Nontuberculous mycobacteria (NTM), a non-contagious cousin of tuberculosis, is showing a marked increase in the U.S. population in recent years. Many of these patients also end up developing bronchiectasis, a condition that inhibits the ability to naturally clear mucous and bacteria from the airways and puts individuals at ever-increasing risk of infection. Find out how COVID-19 is impacting these patients and learn about current and future NTM and bronchiectasis research and treatments.

Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor
Gwen A. Huitt, MD, MS 
Infectious Disease Physician, Division of Mycobacterial & Respiratory Infections
Director, Adult Care Unit
Professor

 

Register Now
 

Autoimmune Diseases, the Impact of COVID-19 and Vaccine Development

Since the early 1980s when they and others discovered the T-cell receptor, the crucial immune-system element that recognizes foreign substances in the body, National Jewish Health scientists and world-renowned immunologists Drs. Philippa Marrack and John Kappler have continued to make significant contributions to our understanding of disease, leading to better therapies for cancer, allergies and other infections. Find out how their current work is helping us move closer to cures and treatments for immune-related lung diseases including scleroderma and sarcoidosis, as well as type 1 diabetes, lupus, multiple sclerosis and more. They will also give an update on the impact of COVID-19 on autoimmune diseases and the importance of delivering a safe and effective COVID-19 vaccine.

John W. Kappler, PhD
Distinguished Professor, Department of Immunology and Genomic Medicine
Philippa Marrack, PhD, FRS
Chair, Department of Immunology and Genomic Medicine
Distinguished Professor

 

Register Now
 

Gastroenterology: The Gut, the Lung and Beyond

Did you know chronic digestive disease can have an impact on allergies as well as lung and autoimmune disease? Our gastroenterologists lead in the understanding of how digestive-related disorders, including gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), colon polyps and cancer, liver disease and more impact the lungs. Hear about research and treatment in this focus area of National Jewish Health.

Jeffrey B. King, MD 
Chief, Division of Gastroenterology
Medical Director, GI Procedures Unit
Associate Professor


 

Register for any or all of these FREE virtual events.

You will receive a Zoom link to the live discussion the day before the event. Speakers subject to change.

Register Now
 

 

Submit questions for the docs.

Submit a Question

Do you have family or friends that might be interested? Share the njhealth.org/docseries link.